Found: 14
Select item for more details and to access through your institution.
Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 7, p. 704, doi. 10.3390/jpm14070704
- By:
- Publication type:
- Article
Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24437-6
- By:
- Publication type:
- Article
The Association of Tumor Immune Microenvironment of the Primary Lesion with Time to Metastasis in Patients with Renal Cell Carcinoma: A Retrospective Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5258, doi. 10.3390/cancers14215258
- By:
- Publication type:
- Article
Thermal Ablation Versus Partial Nephrectomy for cT1 Renal Mass in a Solitary Kidney: A Matched Cohort Comparative Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 3, p. 2133, doi. 10.1245/s10434-023-14646-2
- By:
- Publication type:
- Article
Practical Prediction of New Baseline Renal Function After Partial Nephrectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 2, p. 1402, doi. 10.1245/s10434-023-14540-x
- By:
- Publication type:
- Article
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56461-4
- By:
- Publication type:
- Article
Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer.
- Published in:
- Prostate Cancer (20903111), 2019, p. 1, doi. 10.1155/2019/4050352
- By:
- Publication type:
- Article
Neocapsular reconstruction for challenging partial nephrectomy: A feasibility study in a porcine model and recent clinical experience.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 12, p. 1165, doi. 10.1111/iju.15293
- By:
- Publication type:
- Article
High‐dose‐rate brachytherapy and hypofractionated external beam radiotherapy combined with long‐term androgen deprivation therapy for very high‐risk prostate cancer.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 9, p. 800, doi. 10.1111/iju.14305
- By:
- Publication type:
- Article
Parenchymal volume preservation during partial nephrectomy: improved methodology to assess impact and predictive factors.
- Published in:
- BJU International, 2024, v. 134, n. 2, p. 219, doi. 10.1111/bju.16300
- By:
- Publication type:
- Article
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment.
- Published in:
- Oncology Letters, 2021, v. 21, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 45, n. 2, p. 315, doi. 10.3892/ijmm.2019.4427
- By:
- Publication type:
- Article
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5350, doi. 10.3390/curroncol30060406
- By:
- Publication type:
- Article
Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 4, p. N.PAG, doi. 10.3892/or.2021.8177
- By:
- Publication type:
- Article